Travere Therapeutics (TVTX) Q1 2025 Earnings

Feb 20Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.76
-1.36
-0.96
-0.56

Details

Expected EPS
-0.562024
Actual EPS
-0.73
Surprise EPS
-0.17
Surprise Percent
-29.89%

Description

⁨Travere Therapeutics⁩ (⁦TVTX⁩) has reported earnings of ⁦-0.73⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts